Search

Your search keyword '"Demelo-Rodriguez P."' showing total 98 results

Search Constraints

Start Over You searched for: Author "Demelo-Rodriguez P." Remove constraint Author: "Demelo-Rodriguez P."
98 results on '"Demelo-Rodriguez P."'

Search Results

3. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

4. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

7. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

8. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

9. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

10. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

16. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

17. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

18. Timing and characteristics of venous thromboembolism after noncancer surgery

19. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

20. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

28. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

29. Optimal thromboprophylaxis and anticoagulant strategies in patients with COVID-19 pneumonia. The PROTHROMCOVID Trial

30. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

31. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

32. Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial

33. Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism

34. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

35. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

39. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis

40. Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension

41. Metabolic Syndrome in Heart Failure: Friend or Foe?

43. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

48. Pulmonary Embolism

Catalog

Books, media, physical & digital resources